Literature DB >> 32535963

Effect of pharmaceutical regulatory policy on health impact.

Jennifer H Martin1.   

Abstract

Year:  2020        PMID: 32535963      PMCID: PMC7688524          DOI: 10.1111/bcp.14390

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

1.  Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta-analysis.

Authors:  Christopher J Weatherburn; Bruce Guthrie; Tobias Dreischulte; Daniel R Morales
Journal:  Br J Clin Pharmacol       Date:  2019-12-16       Impact factor: 4.335

2.  The crux of the matter: Did the ABC's Catalyst program change statin use in Australia?

Authors:  Andrea L Schaffer; Nicholas A Buckley; Timothy A Dobbins; Emily Banks; Sallie-Anne Pearson
Journal:  Med J Aust       Date:  2015-06-15       Impact factor: 7.738

3.  Codeine use and harms in Australia: evaluating the effects of re-scheduling.

Authors:  Rose Cairns; Andrea L Schaffer; Jared A Brown; Sallie-Anne Pearson; Nicholas A Buckley
Journal:  Addiction       Date:  2019-11-19       Impact factor: 6.526

4.  Effect of pharmaceutical regulatory policy on health impact.

Authors:  Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2020-06-14       Impact factor: 4.335

Review 5.  Drug repurposing: progress, challenges and recommendations.

Authors:  Sudeep Pushpakom; Francesco Iorio; Patrick A Eyers; K Jane Escott; Shirley Hopper; Andrew Wells; Andrew Doig; Tim Guilliams; Joanna Latimer; Christine McNamee; Alan Norris; Philippe Sanseau; David Cavalla; Munir Pirmohamed
Journal:  Nat Rev Drug Discov       Date:  2018-10-12       Impact factor: 84.694

6.  The Damage-Response Framework as a Tool for the Physician-Scientist to Understand the Pathogenesis of Infectious Diseases.

Authors:  Liise-Anne Pirofski; Arturo Casadevall
Journal:  J Infect Dis       Date:  2018-08-14       Impact factor: 5.226

7.  Does cannabis legalisation change healthcare utilisation? A population-based study using the healthcare cost and utilisation project in Colorado, USA.

Authors:  Francesca N Delling; Eric Vittinghoff; Thomas A Dewland; Mark J Pletcher; Jeffrey E Olgin; Gregory Nah; Kirstin Aschbacher; Christina D Fang; Emily S Lee; Shannon M Fan; Dhruv S Kazi; Gregory M Marcus
Journal:  BMJ Open       Date:  2019-05-15       Impact factor: 2.692

8.  Regulatory Science and Innovation Programme for Europe (ReScIPE): A proposed model.

Authors:  Philip A Hines; Richard H Guy; Angela Brand; Anthony J Humphreys; Marisa Papaluca-Amati
Journal:  Br J Clin Pharmacol       Date:  2019-10-17       Impact factor: 4.335

9.  Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.

Authors:  Thomas Goedecke; Daniel R Morales; Alexandra Pacurariu; Xavier Kurz
Journal:  Br J Clin Pharmacol       Date:  2017-12-20       Impact factor: 4.335

10.  Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection.

Authors:  David S Fedson; Steven M Opal; Ole Martin Rordam
Journal:  mBio       Date:  2020-03-20       Impact factor: 7.867

View more
  1 in total

1.  Effect of pharmaceutical regulatory policy on health impact.

Authors:  Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2020-06-14       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.